Miriam Kidron
2017
In 2017, Miriam Kidron earned a total compensation of $1.3M as Chief Scientific Officer and director at Oramed Pharmaceuticals, a 256% increase compared to previous year.
Compensation breakdown
| Bonus | $50,000 |
|---|---|
| Option Awards | $359,224 |
| Salary | $254,765 |
| Stock Awards | $581,932 |
| Other | $12,775 |
| Total | $1,258,696 |
Kidron received $581.9K in stock awards, accounting for 46% of the total pay in 2017.
Kidron also received $50K in bonus, $359.2K in option awards, $254.8K in salary and $12.8K in other compensation.
Rankings
In 2017, Miriam Kidron's compensation ranked 7,871st out of 14,666 executives tracked by ExecPay. In other words, Kidron earned more than 46.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,871 out of 14,666 | 46th |
Division Manufacturing | 2,952 out of 5,770 | 49th |
Major group Chemicals And Allied Products | 962 out of 2,074 | 54th |
Industry group Drugs | 748 out of 1,730 | 57th |
Industry Pharmaceutical Preparations | 586 out of 1,329 | 56th |
Source: SEC filing on July 30, 2018.
Kidron's colleagues
We found two more compensation records of executives who worked with Miriam Kidron at Oramed Pharmaceuticals in 2017.